Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Dow
Moodys
Mallinckrodt
Harvard Business School

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: peramivir

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

peramivir

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Biocryst RAPIVAB peramivir SOLUTION;INTRAVENOUS 206426 NDA Seqirus USA Inc. 61364-181-03 3 VIAL, GLASS in 1 CARTON (61364-181-03) > 20 mL in 1 VIAL, GLASS (61364-181-01)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
McKesson
Medtronic
Dow
Boehringer Ingelheim